Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid (2015)
- Authors:
- USP affiliated authors: MUSSI, MARISA MARCIA - FMRP ; ISAAC, MYRIAM DE LIMA - FMRP ; CERVI, MARIA CÉLIA - FMRP
- Unidade: FMRP
- DOI: 10.1001/jamapediatrics.2014.3158
- Subjects: TUBERCULOSE (TRATAMENTO); QUIMIOTERAPIA COMBINADA
- Language: Inglês
- Imprenta:
- Source:
- Título: JAMA Pediatrics
- ISSN: 2168-6203
- Volume/Número/Paginação/Ano: v. 169, n. 3, p. 247-255, 2015
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
VILLARINO, M. Elsa et al. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. JAMA Pediatrics, v. 169, n. 3, p. 247-255, 2015Tradução . . Disponível em: https://doi.org/10.1001/jamapediatrics.2014.3158. Acesso em: 08 abr. 2026. -
APA
Villarino, M. E., Scott, N. A., Weis, S. E., Weiner, M., Conde, M. B., Jones, B., et al. (2015). Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. JAMA Pediatrics, 169( 3), 247-255. doi:10.1001/jamapediatrics.2014.3158 -
NLM
Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, Nachman S, Oliveira R, Moro RN, Shang N, Goldberg SV, Sterling TR, Mussi-Pinhata MM, Isaac M de L, Cervi MC. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid [Internet]. JAMA Pediatrics. 2015 ; 169( 3): 247-255.[citado 2026 abr. 08 ] Available from: https://doi.org/10.1001/jamapediatrics.2014.3158 -
Vancouver
Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, Nachman S, Oliveira R, Moro RN, Shang N, Goldberg SV, Sterling TR, Mussi-Pinhata MM, Isaac M de L, Cervi MC. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid [Internet]. JAMA Pediatrics. 2015 ; 169( 3): 247-255.[citado 2026 abr. 08 ] Available from: https://doi.org/10.1001/jamapediatrics.2014.3158 - HIV-1 drug resistance and second-line treatment in children randomized to switch at low versus higher RNA thresholds
- Cryptococcus meningoencephalitis in four children: case report
- Bone paracoccidioidomycosis: case report
- Reactivation congenital toxoplasmosis in mother infected by human immunodeficiency(HIV-1): case report
- Bone mass evaluation in children infected by HIV-1 using highly active retroviral treatment (HAART)
- Neonatal citrobacter koseri brain access: case report
- Rescue therapy with enfuvirtide in adolescents infected with the human immunodeficiency virus (HIV-1): case reports
- Gigant cell glioblastoma in adolescents with infection by the human immunodeficiency virus (HIV-1) and progressive multifocal leukoencephalopathy
- Dyslipidemia in a cohort of HIV-infected latin american children receiving highly active antiretroviral therapy
- Valor de achados clínicos, testes imunológicos, PCR, IgA e P24 para diagnóstico de Infecção pelo HIV
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
